Randomised phase 3 study of S-1 versus capecitabine, with...

European Journal of Cancer 2017 / 02 Vol. 72

Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group

Kwakman, J.J.M., Simkens, L.H.J., Van Rooijen, J.M., Van de Wouw, A.J., Loosveld, O.J.L., Creemers, G.J.M., Hendriks, M.P., Los, M., Van Alphen, R.J., Polée, M.B., Muller, E.W., Van der Velden, A.M.T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
72
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(17)30099-0
Date:
February, 2017
File:
PDF, 54 KB
english, 2017
Conversion to is in progress
Conversion to is failed